The aim of our work was to estimate the maximum strength of the upper and lower limbs (quadriceps, gastrocnemius, biceps, triceps, deltoid) in a group of patients affected by various cardiovascular diseases and compare it with that of a group of healthy and sedentary subjects (n = 20). We also wanted to assess whether there were differences in the maximum strength between different groups of cardiovascular diseases. This study presents many innovative elements, primarily two ones: (a) to recognize the importance of muscle strength as a health component in heart patients; (b) to establish a method for the assessment of strength based on estimation of 1RM. Here are presented the patients recruited on the basis of the basic pathology: 45 patients had chronic heart failure (CHF) in clinical stability for at least 3 months, class NYHA II-III; 21 patients had peripheral obliterative arteriopathy with claudication (POAC, stage IIa of Fontaine); 22 patients had undergone coronary angioplasty (coronary artery disease -CAD); 6 patients had undergone orthotopic cardiac transplant (HT) for at least 6 months. Chronic cardiovascular patients are characterized by a muscular impairment that parallels the history of the disease.
INTRODUCTION
Muscular strength is a fundamental component of exercise and functional capacity, particularly in patients with chronic disease. Muscular strength is positively related to independence, quality of life and ability to perform activities of daily living; and it play also a crucial role in reducing disability and in the prevention of chronic disease 1, 2 .
Patients diagnosed with chronic heart disease display diminished exercise tolerance. This can be attributed not only to a reduction in aerobic capacity, as has been amply demonstrated in the literature 3 , but probably also to a strength deficit such as muscle structure alterations, including muscle weakness and volume reduction, and other pathophysiological mechanisms that underlie both aerobic and strength. The result is that exercise intolerance is a common clinical manifestation in cardiovascular patients 4 .
Indeed, back in the early 1990s, Drexler demonstrated that patients diagnosed with chronic heart failure (CHF) exhibit a particular pattern of myopathy characterized by muscular atrophy and a shift in the distribution of fiber type with a reduced oxidative capacity 5 . The initial loss of type I fibers, which is responsible for endurance, is followed by a consecutive increase in type II fibers. While until not long ago three types of muscle fibers were identified (I; IIa; IIb), currently fibers of the skeletal muscle are classified into four types according to their biochemical characters: (a) slow-twitch type I fatigue-resistant fibers; (b) fast-twitch type IIa fatigue-resistant fibers; (c) fast-twitch type IIx fibers with intermediate fatigue-resistance; (d) and fasttwitch type IIb fatigable fibers 6 .
Recently, Katsuki et al. (2015) demonstrated the activation of Wnt signalling inducted by C1q that seems contributes to fiber type shift toward fatigable fiber. So fiber type shift toward more fatigable type IIb fiber is one of the characteristics observed during the development of skeletal myopathy in cardiovascular patients 7 .
Besides all this, the story of illness leads the patient to a sedentary lifestyle then to atrophy and muscle weakness, and consequently to a "cascade" of events responsible for the diminished exercise tolerance and strength deficit. Strength decreases with the severity of disease for reasons that are in part explained (see above) and in part still unknown.
Poor muscle strength is associated with mortality: persons with poorer baseline strength are more likely to die over a follow-up period of 30 years. Although the mechanism explaining the association between muscle strength and mortality risk remains to be explored, probably the risk of mortality is due to low levels of muscle mass 8 .
Maximum strength of the quadriceps muscle in patients with CHF is an important prognostic index; indeed, in the opinion of some, it is superior to the VO2max 9 . Handgrip strength can predict long term mortality in patients with CHF 10 and 6-month mortality in population with coronary artery disease (CAD) 11 . Other studies found that muscle strength in men without heart disease was inversely and independently associated with all-cause mortality 12, 13 .
While muscular impairment in CHF patients has been amply studied, there are limited case-reports on the strength characteristics of patients affected by other cardiovascular pathologies, such as CAD without ventricular dysfunction. Less attention has been directed also to the issue of post heart transplant (HT) functional capacity 14 .
S94 | 2019 | Proc1 | VOLUME 14 © 2019 University of Alicante This study presents many novelty and innovative elements: (a) to recognize the importance of muscle strength as a health component in heart patients (not only the aerobic component as in the past); (b) to establish a method for the assessment of strength based on estimation of 1RM: (b1) allowing partial information on the severity and history of the disease, (b2) establishing a targeted rehabilitation program (based on % of 1RM), (b3) presenting a protocol that is replicable at any medical sports centre or gymnasium (with simple tools) not just for doing research but also for those who deal with clinical activity and physical training (being able to establish the baseline and to compare the various diseases on a cross sectional design as well as improvements of each patient in a longitudinal direction (other studies have not found who set out with the same goal as will be explained in the discussion stage) 15, 16 .
Taking into account all these premises, the aim of this study was therefore to estimate maximum dynamic strength of the upper and lower limbs (quadriceps, gastrocnemius, biceps, triceps, deltoid) in a group of patients affected by various cardiovascular diseases and compare it with that of a group of healthy and sedentary subjects (n = 20). We also wanted to assess whether there were differences in the maximum strength between different groups of cardiovascular diseases.
METHODS

Subjects involved
Here are presented the patients recruited on the basis of the basic pathology: 45 patients (39 males and 6 females) had chronic heart failure (CHF) in clinical stability for at least 3 months, class NYHA II-III; 21 patients (16 males and 5 females) had peripheral obliterative arteriopathy with claudication (POAC, stage IIa of Fontaine); 22 all male patients had undergone coronary angioplasty (coronary artery disease -CAD); 6 patients (4 males and 2 females) had undergone orthotopic cardiac transplant (HT) for at least 6 months.
Maximum strength estimate of the five muscles tested was significantly lower in patients diagnosed with heart disease compared to the control group. When patients were subdivided according to the type of disease, a clear trend among groups was displayed with maximum strength in lower limbs being higher in controls, followed by the CAD group, then CHF group, the HT group, and POAC group. In the upper limbs CAD was followed by POAC, while the order of the other groups remained unchanged.
Strength evaluation
The maximum strength of the quadriceps and the brachial biceps muscles was assessed by means of submaximal tests. The tests were deemed appropriate when, for a given load, the subject was able to carry out 10 or fewer repetitions of the movement before fatigue. Once the load and the number of repetitions valid for the test had been established, the following indirect formula was used to calculate the value of 1 repetition maximum (1 RM): Predicted 1 RM = Weight Lifted/1.0278-.0278X (where X is the number of reps performed) 17 .
Therefore, predicted 1 RM refers to the maximum weight estimate a person can lift only once in a complete range of motion 17 . Maximum strength of each muscle was obtained through the normalization of 1 RM (kg) by body weight (kg) to avoid the influence of other variables such as muscle mass 9 . Average strength of the muscles of both right and left limbs was considered. During testing, the patient's electrocardiogram was constantly monitored telemetrically.
Strength testing, in which each exercise involves a contraction phase and a relaxation phase of 2 seconds, comprised.
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Before the measurement began, the subjects were instructed to warm up for about 10 min (including 5 min of cycling and 5 min of mobility and free movements of the arms and legs). After warming up, the subjects were familiarized with the device by performing 8-10 repetitions at the lowest load, then the load was gradually increased until reaching the optimal load. All tests were performed by the same two technicians. Only moderate standardized verbal encouragement was given to all participants during the test.
Statistical Analysis
All data were processed using the SPSS 18.0 program. Age and anthropometric characteristics are expressed as mean value ± standard deviation. Comparisons between groups were analysed by unpaired t test (2-sided) or Analysis of variance (one-way ANOVA) for comparisons with >2 subgroups. Bonferroni posthoc multiple comparisons were performed when appropriate. The alpha-error probability was set at p<.05 (2-sided). When examining the difference between two conditions, effect size was calculated using Cohen's d. When variables were more than two, effect size was calculated using eta squared ( 2 ).
RESULTS
Group comparisons between patients overall and controls are shown in Figure 1 [±95% confidence interval]. Maximum strength of quadriceps muscles was significantly lower in patients (M=1.76; SD=.59) compared to the control group (M=2.46; SD=.62) with a difference of 31% (p=.0001; d=1. 15) . Maximum strength of brachial biceps muscle was significantly lower in patients (M=.19; SD=.03) compared to the control group (M=.13; SD=.03) with a difference of 32% (p<.0001; d=2.00).
One-way ANOVA showed between-group differences in maximum strength of both quadriceps (F1,169=14.37, p=.0001) and brachial biceps (F1,169=27.21, p=.0001) muscles while there were no significant differences in maximum strength for the other muscles.
When patients were subdivided according to the type of disease, although strength differences were not always significant, a clear trend among groups was displayed with maximum strength being higher in controls, followed by the POAC group, then the CAD group, the CHF group, and the HT group [±95% confidence interval]. The group of patients diagnosed with diabetes did not differ from other patients in maximum strength of both quadriceps (p = .06) and brachial biceps (p = .06) muscles respectively.
DISCUSSION
Cardiovascular rehabilitation is a well-established means of improving the functional capacity, physiological outcomes, quality of life and psychological well-being in patients with cardiovascular disease [18] [19] [20] . Resistance training is now recommended as a component of cardiac rehabilitation by the major guidelines 1,2,19 . As it happen in aerobic training, for a correct strength training prescription, it is necessary to be aware of the baseline status of the patients in order to develop a training program that effectively stresses peripheral muscles without creating cardiovascular overload. To our knowledge, no previous studies compared the baseline strength status in different types of chronic heart disease. Therefore, the purpose of the present study was to estimate maximum dynamic strength of the two primary antigravity muscles of upper and lower limbs in three categories of patients with chronic heart disease: POAC, CAD, CHF, and HT.
Unlike most of the studies reported in the literature, which have utilized isokinetic testing, our study evaluated patients by means of a different technique. We decided to evaluate dynamic maximum strength estimating 1 RM (using free weights and a machine) rather than assessing isokinetic force, work, and power or isometric S96 | 2019 | Proc1 | VOLUME 14 © 2019 University of Alicante force 1 . Our decision was dictated by the need to utilize a test that would be both simple and reliable, and which would require inexpensive equipment that enabled us to identify the training work-load and to formulate strength training prescriptions to be implemented not only in hospital but also in local gymnasiums 16 .
Note. *p<.001 Figure 1 . Maximum strength estimate of the patients enrolled compared with a control group (±95% confidence interval: mean ± 2 standard error of mean) Strength assessment revealed that the maximum strength of the heart disease patients was 28-32% less than that of a control group of age-matched healthy sedentary subjects (see Figure 1 ). This should come as no surprise since patients with chronic heart disease often experience impairment, functional limitation and disability due to deteriorating health. Since our patients expressed a great variability in type of disease, disease severity, and in the concurrence of other chronic conditions we decided to estimate maximum strength according to the type of heart disease.
When the patients were subdivided according to the disease, it clearly emerged that the strongest patients with regard to both the muscle groups were those in the POAC group, followed by CAD group, the CHF group, and then the HT group. This is the logical consequence of the history of the disease. Indeed, patients who undergo angioplasty often come in for the procedure without having ever suffered from any symptoms that might prompt them to limit their physical effort, or else with symptoms of recent onset. Moreover, hospitalizations are usually very short. At any rate, although CAD group was found to be the strongest group in patient sample, maximum strength of the lower limbs was significantly lower (19%) than that of the control group. This finding seems to confirm the data of previous studies on strength in patients diagnosed with coronary disease: Ghroubi reported a 25% strength deficit in the lower limbs on isokinetic testing 21 and Gayda a diminished resistance to isometric effort 22 . The small discrepancy between the studies may be accounted for by the differences in strength testing technique as well as the control group: while we enrolled age matched healthy sedentary subjects with no previous muscle strength training experience, the above mentioned studies compared the patients to a group of physically active age matched controls.
The natural history of patients diagnosed with CHF is different: repeated hospitalizations together with the pivotal symptoms of heart failure, asthenia and effort dyspnea, prompt patients to limit themselves with regard not only to strenuous effort but also to moderate activity, even to the extent of impairing normal everyday actions in patients with longstanding disease. To this, we may add the effect of malnutrition, which VOLUME 14 | Proc1 | 2019 | S97 complicates the clinical picture in patients who are in the most advanced functional class 23 . So, the fact that this group of patients reported a strength deficit of about 31% compared to the control group, is not surprising.
HT patients seem to be the weakest of all, even if data are not always significant owing to the small size of the sample and the variability in years of disease prior to the transplant. Nevertheless, HT is often an effective treatment option for patients with end-stage CHF. Most patients who undergo transplantation spend long periods in bed before the operation. Muscular weakness and fatigue are the primary limiting symptoms in the day to day activities of many of these patients. Moreover, the immunosuppressive and cortisone therapy required after transplantation weakens the muscles further. Back in the 1993, Braith et al. 24 estimated that the quadriceps muscle strength of patients with HT is 60-70% of that in age-matched controls. Our study seems to consolidate this data but with a lower estimate of the deficit in HT recipients (52%).
Summarizing, the present study showed that chronic cardiovascular patients are characterized by a muscular impairment that parallels the history of the disease: baseline strength status decreases with the increase of the disease severity.
To our knowledge, no previous studies measured maximum strength of small muscle groups in patients with chronic heart disease. The novelty of this study was not only to estimate the maximum strength of the quadriceps but also that of the brachial biceps in three categories of patients with chronic heart disease (CAD, CHF, and HT), which showed a similar trend of quadriceps muscle.
IMPLICATIONS
Resistance training is not only safe and practicable 25 but it also plays a crucial role in cardiovascular rehabilitation setting. It has a lot of benefits such as enhancing muscular strength, functional capacity, independence, quality of life and reducing disability 17 . This study shows that patients with chronic heart disease have a strength impairment which parallels the history of disease. In our opinion this peripheral deconditioning requires a different approach in the rehabilitation setting. Different types of heart disease show a different trend of strength: it is therefore necessary to evaluate the strength baseline status to be able to train strength, identifying the most appropriate work-load. A strength training with lower loads for a more prolonged period of time seems advisable in the local gymnasium setting 16 . This lower intensity phase should yield an initial aerobic and strength reconditioning which is recommended before switching to higher intensity training 26 .
LIMITATIONS
This study presents other two limitations: a lack of data on body composition, and specifically on lean body mass; muscle biopsy was not performed to report on muscle physiology.
CONCLUSIONS
The maximum strength of both quadriceps and the brachial biceps muscles is significantly lower in patients diagnosed with chronic heart disease than in healthy control subjects. Moreover, it seems that chronic cardiovascular patients are characterized by a muscular impairment that parallels the history of the disease. This information should be kept in mind when planning a rehabilitation program.
